These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 11586280)
1. Use of intravenous gamma globulins in neuroimmunologic diseases. Latov N; Chaudhry V; Koski CL; Lisak RP; Apatoff BR; Hahn AF; Howard JF J Allergy Clin Immunol; 2001 Oct; 108(4 Suppl):S126-32. PubMed ID: 11586280 [TBL] [Abstract][Full Text] [Related]
2. Intravenous immune globulin therapy for neurologic diseases. Dalakas MC Ann Intern Med; 1997 May; 126(9):721-30. PubMed ID: 9139559 [TBL] [Abstract][Full Text] [Related]
3. Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee. Tavee J; Brannagan TH; Lenihan MW; Muppidi S; Kellermeyer L; D Donofrio P; Muscle Nerve; 2023 Oct; 68(4):356-374. PubMed ID: 37432872 [TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin in autoimmune neuromuscular diseases. Dalakas MC JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209 [TBL] [Abstract][Full Text] [Related]
5. Guidelines on the use of intravenous immune globulin for neurologic conditions. Feasby T; Banwell B; Benstead T; Bril V; Brouwers M; Freedman M; Hahn A; Hume H; Freedman J; Pi D; Wadsworth L Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S57-107. PubMed ID: 17397768 [TBL] [Abstract][Full Text] [Related]
6. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status. Illa I J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667 [TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin treatment of neurological autoimmune diseases. Stangel M; Hartung HP; Marx P; Gold R J Neurol Sci; 1998 Jan; 153(2):203-14. PubMed ID: 9511879 [TBL] [Abstract][Full Text] [Related]
8. Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review. Fergusson D; Hutton B; Sharma M; Tinmouth A; Wilson K; Cameron DW; Hebert PC Transfusion; 2005 Oct; 45(10):1640-57. PubMed ID: 16181216 [TBL] [Abstract][Full Text] [Related]
9. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin. Soueidan SA; Dalakas MC Pediatr Res; 1993 Jan; 33(1 Suppl):S95-100. PubMed ID: 8433882 [TBL] [Abstract][Full Text] [Related]
10. The current place of high-dose immunoglobulins in the treatment of neuromuscular disorders. van der Meché FG; van Doorn PA Muscle Nerve; 1997 Feb; 20(2):136-47. PubMed ID: 9040650 [TBL] [Abstract][Full Text] [Related]
11. Can we face the challenge of expanding use of intravenous immunoglobulin in neurology? Elovaara I; Hietaharju A Acta Neurol Scand; 2010 Nov; 122(5):309-15. PubMed ID: 20085560 [TBL] [Abstract][Full Text] [Related]
12. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases. Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B; Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075 [TBL] [Abstract][Full Text] [Related]
15. Drug Insight: the use of intravenous immunoglobulin in neurology--therapeutic considerations and practical issues. Gold R; Stangel M; Dalakas MC Nat Clin Pract Neurol; 2007 Jan; 3(1):36-44. PubMed ID: 17205073 [TBL] [Abstract][Full Text] [Related]
16. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Patwa HS; Chaudhry V; Katzberg H; Rae-Grant AD; So YT Neurology; 2012 Mar; 78(13):1009-15. PubMed ID: 22454268 [TBL] [Abstract][Full Text] [Related]
17. Using immunoglobulins in muscular disease treatment. Pul R; Stangel M Expert Opin Biol Ther; 2008 Aug; 8(8):1143-50. PubMed ID: 18613765 [TBL] [Abstract][Full Text] [Related]